Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024
Compare Balance Sheet Results of Asston Pharmaceu
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.27
11.29
-5.02
-44.46%
Share Warrants & Outstandings
Total Reserve
4.76
-5.64
10.40
184.40%
Shareholder's Funds
11.04
8.55
2.49
29.12%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.26
0.00
2.26
0.00%
Secured Loans
0.80
0.00
0.80
0.00%
Unsecured Loans
1.45
0.00
1.45
0.00%
Deferred Tax Assets / Liabilities
-0.02
0.00
-0.02
0.00%
Other Long Term Liabilities
0.16
0.00
0.16
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.39
0.00
2.39
0.00%
Current Liabilities
Trade Payables
5.97
0.11
5.86
5,327.27%
Other Current Liabilities
3.70
0.00
3.70
0.00%
Short Term Borrowings
5.00
0.00
5.00
0.00%
Short Term Provisions
0.00
0.03
-0.03
-100.00%
Total Current Liabilities
14.67
0.14
14.53
10,378.57%
Total Liabilities
28.10
8.69
19.41
223.36%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.10
0.00
1.10
0.00%
Less: Accumulated Depreciation
0.14
0.00
0.14
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.96
0.00
0.96
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
0.00
2.98
-2.98
-100.00%
Total Non-Current Assets
0.96
2.98
-2.02
-67.79%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.72
0.00
0.72
0.00%
Sundry Debtors
24.55
0.00
24.55
0.00%
Cash and Bank
0.20
2.92
-2.72
-93.15%
Other Current Assets
0.14
0.00
0.14
0.00%
Short Term Loans and Advances
1.55
2.79
-1.24
-44.44%
Total Current Assets
27.15
5.71
21.44
375.48%
Net Current Assets (Including Current Investments)
12.47
5.57
6.90
123.88%
Total Current Assets Excluding Current Investments
27.15
5.71
21.44
375.48%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.10
8.69
19.41
223.36%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.26
0.00
7.26
0.00%
Book Value per share (adjusted)
17.60
5.01
12.59
251.30%
Annual - Borrowings
Borrowings 7.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 27.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024
